Certified by Founder Lodge
Eli Lilly and Company
United States - Indianapolis, Indiana
INVESTOR
1 Disclosed Funding Rounds $97,000,000
45 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs,
| Company | Date | Round | Raised |
|---|---|---|---|
 Laverock Therapeutics |
September, 28 ,2023 | Seed | $16,470,000 |
 Amber Bio |
August, 04 ,2023 | Seed | $26,000,000 |
 Volastra Therapeutics |
March, 08 ,2023 | Series A | $60,000,000 |
 Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 Switch Therapeutics |
March, 15 ,2023 | Series A | $52,000,000 |
 Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
| Laverock Therapeutics |
September, 28 ,2023 | Seed | $16,470,000 |
 Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
 Therini Bio, Inc. |
April, 27 ,2023 | Series A | $36,000,000 |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
 Alto Neuroscience |
November, 22 ,2023 | Series C | $45,000,000 |
 DiogenX |
May, 11 ,2023 | Series A | $30,056,125 |
| OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Mozart Therapeutics, Inc |
June, 08 ,2023 | Series A | $25,000,000 |
| Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
 AltPep |
June, 26 ,2023 | Series B | $53,000,000 |
 Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Alto Neuroscience |
November, 22 ,2023 | Series C | $45,000,000 |
 Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 Artax Biopharma Inc |
August, 07 ,2024 | Unknown | $8,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Amber Bio |
August, 04 ,2023 | Seed | $26,000,000 |
 Arda Therapeutics |
October, 10 ,2024 | Series A | $43,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Mariana Oncology |
September, 08 ,2023 | Series B | $175,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Artax Biopharma Inc |
August, 07 ,2024 | Unknown | $8,000,000 |
| Laverock Therapeutics |
September, 28 ,2023 | Seed | $16,470,000 |
 Revisto |
November, 19 ,2024 | Seed | $4,000,000 |
| Arda Therapeutics |
October, 10 ,2024 | Series A | $43,000,000 |
| Sitryx |
September, 28 ,2023 | Unknown | $39,500,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
| Revisto |
November, 19 ,2024 | Seed | $4,000,000 |
| Vianautis |
November, 14 ,2023 | Series A | $25,000,000 |
| Alto Neuroscience |
November, 22 ,2023 | Series C | $45,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Myricx Bio |
July, 09 ,2024 | Series A | $115,246,800 |
| Artax Biopharma Inc |
August, 07 ,2024 | Unknown | $8,000,000 |
| Arda Therapeutics |
October, 10 ,2024 | Series A | $43,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Revisto |
November, 19 ,2024 | Seed | $4,000,000 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
